Research Grants 7 show all


$69.8K
2003

$250K
2005

$250K
2006

$491K
2017

$655.9K
2018

Patents 116show all

  • 37
    A61K - Preparations for medical, dental, or toilet purposes
  • 27
    C12N - Microorganisms or enzymes
  • 13
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 7
    C07D - Heterocyclic compounds
  • 3
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 2
    A61B - Diagnosis
  • 1
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 7show all

4Phase 12Phase 2

SEC Filings show all


267
8-K

37
10-Q

12
10-K

8
D

1
S-1

Contact Information

Germantown, MD
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-12-04$10,000,000$10,000,000Debt, Option to Acquire, Security to be Acquired
2013-04-10$1,778,000$1,778,000Equity, Debt, Option to Acquire
2010-01-05$1,500,000$1,500,000Equity
2007-03-21Unknown Unknown Other (Paper Filing)

Key Executives

  • Richard Garr
    Director, Executive Officer
  • Karl Johe
    Director, Executive Officer
  • Scott Ogilvie
    Director
  • William Oldaker
    Director
  • John Conron
    Executive Officer
  • Richard I. Garr
    Executive Officer, Director
  • Stanley Westreich
    Director
  • I. Richard Garr
    Executive Officer, Director
  • Catherine A. Sohn
    Director
  • Sandford D. Smith
    Director